Trial Profile
Clinical Trials Insight: 700030680
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Feb 2008
Price :
$35
*
At a glance
- Drugs Adomiparin (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Sponsors Momenta Pharmaceuticals
- 20 Feb 2008 New trial record.